Activity of oral atovaquone alone and in combination with antimony in experimental visceral Leishmaniasis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 586-587

  Murray, Henry W ^a   Hariprashad, June ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; ANTIMONY; ATOVAQUONE; STIBOGLUCONATE SODIUM; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY BURDEN; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LEISHMANIA DONOVANI; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

EID: 0030043869     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.586     Document Type: Article

References (19)

1. Brun-Pascaud, M., F. Chau, A. Simonpoli, P. Girard, F. Derouin, and J. Pocidalo. 1994. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis. J. Infect. Dis. 170:653-658.
2. Chunge, C. N., J. Owate, H. O. Pamba, and L. Donno. 1990. Treatment of visceral leishmaniaisis in Kenya by aminosidine alone or combined with sodium stibogluconate. Trans. R Soc. Med. Hyg 84:221-225.
3. Croft, S. L., J. Hogg, W. E. Gutteridge, A. T. Hudson, and A. W, Randall. 1992 The activity of hydroxynaphthoquinones against Leishmania donovam. J. Antimicrob. Chemother. 30:827-832.
4. Herwaldt, B. L., and J. D. Berman. 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am. J Trop Med. Hyg. 46:296-306.
5. Hughes, W. T. 1992 A new drug (566C80) for the treatment of Pneumocystis cannu pneumonia. Ann. Intern. Med. 116:953-954.
6. Hughes, W. T., V. L. Gray, W. E. Gutteridge, V. S. Latter, and M. Pudney. 1990. Efficacy of a hydroxynaphthoquinone. 566C80, in experimental Pneumocystis cannu pneumonitis Antimicrob. Agents Chemother. 34:225-228.
7. Jernigan, J. A., R. D. Pearson, M. D. Rogers, and W. A. Petri. 1993. In vitro activity of atovaquone against Leishmania chagasi promastigotes, abstr. 752, p. 257. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C
8. Mishra, M., U. K. Biswas, A. M. Jha, and A. B. Khan. 1994. Amphotericin versus sodium stibogluconate in the first-line treatment of Indian kala-azar. Lancet 344:1599-1600
9. Murray, H. W., J. D. Berman, and S. D. Wright. 1988 Immunochemotherapy for intracellular Leishmania donovani infection. interferon-γ plus pentavalent antimony. J. Infect. Dis 157:973-979
10. Murray, H. W., J. Hariprashad, and R. E, Fichtl. 1993. Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine Antimicrob. Agents Chemother. 37:1504-1505.
11. Olliaro, P. L., and A. D. M. Bryceson, 1993. Practical progress and new drugs for changing patterns of leishmaniasis. Parsitol. Today 9:323-328
12. Romand, S., M. Pudney, and F. Derouin. 1993. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii Antimicrob Agents Chemother. 37:2371-2378.
13. Seaman, J., D. Pryce, H. E. Sondorp, and A. D. M. Bryceson. 1993. Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. J. Infect. Dis. 168:715-720
14. Sherwood, J. A., G. S. Gachihi, R, Muigai, D. R. Skillman, M. Mugo, J. R. Rashid, K. Wasunna, S. K. Kasili, G. Kirigi, C. N. Oster, L. L. Fleckstein, J. D. Berman, T. G. Brewster, C. R. Roberts, A. J. Johnson, and B. G. Schuster. 1994. Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis. Clin. Infect Dis. 19:1034-1039.
15. Sundar, S., F. Rosenkaimer, M. L. Lesser, and H. W. Murray. 1995. Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-γ in visceral leishmaniasis. J. Infect. Dis. 171:992-996.
16. Sundar, S., F. Rosenkaimer, and H. W. Murray. 1994. Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-γ. J. Infect. Dis. 170:659-662
17. Thakur, C. P., M. Kumar, P. Kumar, B. N. Mishra, and A. K. Pandey. 1988. Rationalization of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomized study. Br. Med. J. 296:1557-1661.
18. Thakur, C. P., M. Kumar, and A. K. Pandey. 1991. Comparison of regimens of treatment of antimony-resistant kala-azar patients. Am. J. Trop. Med. Hyg. 45:435-441.
19. Woolley, J. L. (Glaxo Wellcome Co.). Personal communication